Ex Vivo News and Research

RSS
EMA designates Osiris as Orphan Drug title holder for Prochymal

EMA designates Osiris as Orphan Drug title holder for Prochymal

Gamida Cell announces results from NiCord Phase I/II study on hematological malignancies

Gamida Cell announces results from NiCord Phase I/II study on hematological malignancies

Sucampo receives supplement approval from FDA for AMITIZA

Sucampo receives supplement approval from FDA for AMITIZA

TransMedics closes $36 million financing round

TransMedics closes $36 million financing round

Functional profiling using EVA/PCD doubles response rate and improves survival in NSCLC patients

Functional profiling using EVA/PCD doubles response rate and improves survival in NSCLC patients

CytoDyn announces update on feline immunodeficiency virus therapeutic antibody program

CytoDyn announces update on feline immunodeficiency virus therapeutic antibody program

Life Technologies receives FDA clearance for OpTmizer CTS T-cell expansion media

Life Technologies receives FDA clearance for OpTmizer CTS T-cell expansion media

Wiley announces publication of 6-volume Encyclopedia of Drug Metabolism and Interactions

Wiley announces publication of 6-volume Encyclopedia of Drug Metabolism and Interactions

MU endocrinologist to receive American Heart Association lifetime achievement award

MU endocrinologist to receive American Heart Association lifetime achievement award

Enrollment complete in Gamida Cell’s NiCord Phase I/II trial for hematological malignancies

Enrollment complete in Gamida Cell’s NiCord Phase I/II trial for hematological malignancies

New results describe development of DC cancer vaccine with enhanced immunogenic potential

New results describe development of DC cancer vaccine with enhanced immunogenic potential

Arteriocyte receives NIH grant for use of NANEX platform in bone marrow transplant

Arteriocyte receives NIH grant for use of NANEX platform in bone marrow transplant

European collaboration to design a biomimetic bioartificial liver

European collaboration to design a biomimetic bioartificial liver

Data from Infinity’s IPI-145 pre-clinical study on inflammatory diseases

Data from Infinity’s IPI-145 pre-clinical study on inflammatory diseases

Novel technique helps surgeons to remove 'inoperable' abdominal tumors

Novel technique helps surgeons to remove 'inoperable' abdominal tumors

TGF-β molecule ramps up the immune system in some cases and suppress it in others

TGF-β molecule ramps up the immune system in some cases and suppress it in others

Non-invasive and longitudinal assessment of fat in animal disease models

Non-invasive and longitudinal assessment of fat in animal disease models

UCSD surgeons perform west coast's first ex-vivo liver resection

UCSD surgeons perform west coast's first ex-vivo liver resection

Woman's ovarian cycle plays an important role in her susceptibility to infection

Woman's ovarian cycle plays an important role in her susceptibility to infection

Promising results from Fate Therapeutics' ProHema Phase 1b trial on hematologic malignancies

Promising results from Fate Therapeutics' ProHema Phase 1b trial on hematologic malignancies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.